| Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity BP Gonçalves, MC Kapulu, P Sawa, WM Guelbéogo, AB Tiono, ... Nature communications 8 (1), 1133, 2017 | 216 | 2017 |
| Measuring the blockade of malaria transmission–an analysis of the standard membrane feeding assay TS Churcher, AM Blagborough, M Delves, C Ramakrishnan, MC Kapulu, ... International journal for parasitology 42 (11), 1037-1044, 2012 | 181 | 2012 |
| The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density HC Slater, A Ross, I Felger, NE Hofmann, L Robinson, J Cook, ... Nature communications 10 (1), 1433, 2019 | 163 | 2019 |
| Comparative Assessment of Transmission-Blocking Vaccine Candidates against Plasmodium falciparum MC Kapulu, DF Da, K Miura, Y Li, AM Blagborough, TS Churcher, ... Scientific reports 5 (1), 11193, 2015 | 139 | 2015 |
| Ethics of controlled human infection to address COVID-19 SK Shah, FG Miller, TC Darton, D Duenas, C Emerson, HF Lynch, ... Science 368 (6493), 832-834, 2020 | 133 | 2020 |
| Ethical considerations in controlled human malaria infection studies in low resource settings: experiences and perceptions of study participants in a malaria challenge study in … M Njue, P Njuguna, MC Kapulu, G Sanga, P Bejon, V Marsh, S Molyneux, ... Wellcome open research 3, 2018 | 70 | 2018 |
| Detecting malaria hotspots: a comparison of rapid diagnostic test, microscopy, and polymerase chain reaction P Mogeni, TN Williams, I Omedo, D Kimani, JM Ngoi, J Mwacharo, ... The Journal of infectious diseases 216 (9), 1091-1098, 2017 | 60 | 2017 |
| Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group E Jamrozik, K Littler, S Bull, C Emerson, G Kang, M Kapulu, E Rey, ... Vaccine 39 (4), 633-640, 2021 | 56 | 2021 |
| Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors MG Cottingham, F Carroll, SJ Morris, AV Turner, AM Vaughan, MC Kapulu, ... Biotechnology and bioengineering 109 (3), 719-728, 2012 | 56 | 2012 |
| Assessment of antibodies induced by multivalent transmission-blocking malaria vaccines V Menon, MC Kapulu, I Taylor, K Jewell, Y Li, F Hill, CA Long, K Miura, ... Frontiers in immunology 8, 1998, 2018 | 46 | 2018 |
| Detection of Plasmodium falciparum infected Anopheles gambiae using near-infrared spectroscopy MF Maia, M Kapulu, M Muthui, MG Wagah, HM Ferguson, FE Dowell, ... Malaria journal 18, 1-11, 2019 | 44 | 2019 |
| Controlled Human Malaria Infection in Semi-Immune Kenyan Adults (CHMI-SIKA): a study protocol to investigate in vivo Plasmodium falciparum malaria parasite growth in the … MC Kapulu, P Njuguna, MM Hamaluba, Chmi-Sika Study Team Wellcome open research 3, 2018 | 42 | 2018 |
| Ethical and scientific considerations on the establishment of a controlled human infection model for schistosomiasis in Uganda: report of a stakeholders’ meeting held in … AM Elliott, M Roestenberg, A Wajja, C Opio, F Angumya, M Adriko, ... AAS open research 1, 2018 | 42 | 2018 |
| malERA: An updated research agenda for characterising the reservoir and measuring transmission in malaria elimination and eradication malERA Refresh Consultative Panel on Characterising the Reservoir and ... PLoS medicine 14 (11), e1002452, 2017 | 42 | 2017 |
| Evaluation of two lead malaria transmission blocking vaccine candidate antibodies in natural parasite-vector combinations A Bompard, DF Da, RS Yerbanga, S Biswas, M Kapulu, T Bousema, ... Scientific Reports 7 (1), 6766, 2017 | 39 | 2017 |
| Deliberately infecting healthy volunteers with malaria parasites: Perceptions and experiences of participants and other stakeholders in a Kenyan‐based malaria infection study I Jao, V Marsh, P Che Chi, M Kapulu, M Hamaluba, S Molyneux, P Bejon, ... Bioethics 34 (8), 819-832, 2020 | 23 | 2020 |
| Gametocyte carriage in an era of changing malaria epidemiology: A 19-year analysis of a malaria longitudinal cohort MK Muthui, P Mogeni, K Mwai, C Nyundo, A Macharia, TN Williams, ... Wellcome open research 4, 2019 | 23 | 2019 |
| Safety and PCR monitoring in 161 semi-immune Kenyan adults following controlled human malaria infection MC Kapulu, P Njuguna, M Hamaluba, D Kimani, JM Ngoi, J Musembi, ... JCI insight 6 (17), 2021 | 22 | 2021 |
| Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response MC Kapulu, D Kimani, P Njuguna, M Hamaluba, E Otieno, R Kimathi, ... BMC infectious diseases 22 (1), 86, 2022 | 21 | 2022 |
| Hepatosplenic schistosomiasis is characterised by high blood markers of translocation, inflammation and fibrosis E Sinkala, MC Kapulu, E Besa, K Zyambo, NJ Chisoso, GR Foster, P Kelly Liver International 36 (1), 145-150, 2016 | 21 | 2016 |
Philip BejonKEMRI-WellcomeVerified email at kemri-wellcome.org
